Showing results (131-140 of 144) with videos related to

Sort By:
Pageof 15
Cancer Discovery|April 2, 2017
A Phase Ib Dose-Escalation Study of Encorafenib and Cetuximab with or without Alpelisib in Metastatic <i>BRAF</i>-Mutant Colorectal CancerRobin M J M van Geel, Josep Tabernero, Elena Elez, et al.
British Journal of Cancer|March 10, 2020
Phase 1 study of the pan-HER inhibitor dacomitinib plus the MEK1/2 inhibitor PD-0325901 in patients with KRAS-mutation-positive colorectal, non-small-cell lung and pancreatic cancerRobin M J M van Geel, Emilie M J van Brummelen, Ferry A L M Eskens, et al.
Multiple Sclerosis and Related Disorders|March 17, 2019
Caregiver strain among life partners of persons with mild disability due to relapsing-remitting multiple sclerosisK van der Hiele, D A M van Gorp, M A P Heerings, et al.
Cancers|September 10, 2021
Thermal Ablation versus Stereotactic Ablative Body Radiotherapy to Treat Unresectable Colorectal Liver Metastases: A Comparative Analysis from the Prospective Amsterdam CORE RegistrySanne Nieuwenhuizen, Madelon Dijkstra, Robbert S Puijk, et al.
European Journal of Cancer (Oxford, England : 1990)|June 8, 2026
Model-informed approaches to develop drug cost-saving dosing strategies for pembrolizumabYan Wang, Laura H Bukkems, Johan G C van Hasselt, et al.
International Journal of Cancer|October 16, 2023
Exploring the impact of patient-specific clinical features on osimertinib effectiveness in a real-world cohort of patients with EGFR mutated non-small cell lung cancerArd van Veelen, G D Marijn Veerman, Marjon V Verschueren, et al.
Cancer Research|June 18, 2016
Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF-Mutant Colorectal CancerDaniele Oddo, Erin M Sennott, Ludovic Barault, et al.
Bone|May 11, 2017
The association between insulin use and volumetric bone mineral density, bone micro-architecture and bone strength of the distal radius in patients with type 2 diabetes - The Maastricht studyE A C de Waard, J H M Driessen, J J A de Jong, et al.
Targeted Oncology|April 20, 2023
A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung CancerRob Ter Heine, Michel M van den Heuvel, Berber Piet, et al.
Multiple Sclerosis and Related Disorders|June 15, 2026
Real world drug utilization patterns in the first years following a relapsing-remitting multiple sclerosis diagnosisP C G Molenaar, D L Weir, E P J Arnoldus, et al.
Pageof 15